Where will the UPC be based?

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Where will the UPC be based?

upc-map-updated-crop-55.jpg

Following recent announcements, we have updated our map showing the locations of the UPC courts and divisions

The Irish government this week confirmed that the country intends to host a local division of the Unified Patent Court in Dublin.

The announcement was welcomed by Irish practitioners, and may prove attractive particularly to US high-tech and pharma companies, many of whom have significant operations in the country.

The map below shows the confirmed locations of the UPC central division, Court of Appeal, mediation and training centres, as well as the locations of local divisions that have already been announced or are expected.

Spain, Poland and Croatia, which are not expected to take part in the UPC at the launch, are shaded pale.

We will update the map when further announcements are made. If you have any relevant information, please let us know using the Comment facility.

Layout 1

more from across site and SHARED ros bottom lb

More from across our site

The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Gift this article